Mel Greaves

41.3k total citations · 4 hit papers
167 papers, 13.8k citations indexed

About

Mel Greaves is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Mel Greaves has authored 167 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Public Health, Environmental and Occupational Health, 67 papers in Hematology and 58 papers in Molecular Biology. Recurrent topics in Mel Greaves's work include Acute Lymphoblastic Leukemia research (95 papers), Acute Myeloid Leukemia Research (54 papers) and Chronic Myeloid Leukemia Treatments (27 papers). Mel Greaves is often cited by papers focused on Acute Lymphoblastic Leukemia research (95 papers), Acute Myeloid Leukemia Research (54 papers) and Chronic Myeloid Leukemia Treatments (27 papers). Mel Greaves collaborates with scholars based in United Kingdom, United States and Italy. Mel Greaves's co-authors include Carlo C. Maley, Anthony M. Ford, Joe Wiemels, Tariq Enver, Charles G. Mullighan, Hiroto Inaba, Joseph L. Wiemels, Susan Colman, Ana-Teresa Maia and Osborn B. Eden and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Mel Greaves

167 papers receiving 13.4k citations

Hit Papers

Clonal evolution in cancer 2010 2026 2015 2020 2012 2013 2010 2018 500 1000 1.5k 2.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mel Greaves 6.0k 5.6k 5.0k 2.8k 2.7k 167 13.8k
Sheila Shurtleff 3.8k 0.6× 5.2k 0.9× 4.4k 0.9× 3.0k 1.1× 1.2k 0.5× 96 10.8k
Charles G. Mullighan 9.8k 1.6× 5.9k 1.1× 8.3k 1.6× 3.9k 1.4× 4.5k 1.7× 299 19.0k
Nyla A. Heerema 5.9k 1.0× 4.9k 0.9× 6.1k 1.2× 2.6k 0.9× 2.9k 1.1× 357 16.5k
Christine J. Harrison 7.3k 1.2× 4.5k 0.8× 9.5k 1.9× 2.0k 0.7× 2.5k 0.9× 258 14.1k
Brent L. Wood 4.6k 0.8× 4.3k 0.8× 6.6k 1.3× 5.8k 2.1× 1.7k 0.6× 313 16.9k
Jeffrey E. Rubnitz 8.3k 1.4× 4.1k 0.7× 8.0k 1.6× 2.8k 1.0× 4.1k 1.5× 278 14.9k
Cheryl L. Willman 6.5k 1.1× 8.4k 1.5× 12.3k 2.5× 4.6k 1.6× 2.1k 0.8× 235 20.5k
Martin Schrappe 11.8k 2.0× 4.5k 0.8× 7.5k 1.5× 3.8k 1.4× 6.2k 2.3× 387 18.7k
Stephen P. Hunger 12.3k 2.1× 4.2k 0.8× 7.4k 1.5× 4.0k 1.4× 7.3k 2.7× 374 18.2k
Arndt Borkhardt 2.5k 0.4× 4.6k 0.8× 2.8k 0.6× 1.7k 0.6× 1.1k 0.4× 342 10.2k

Countries citing papers authored by Mel Greaves

Since Specialization
Citations

This map shows the geographic impact of Mel Greaves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel Greaves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel Greaves more than expected).

Fields of papers citing papers by Mel Greaves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mel Greaves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel Greaves. The network helps show where Mel Greaves may publish in the future.

Co-authorship network of co-authors of Mel Greaves

This figure shows the co-authorship network connecting the top 25 collaborators of Mel Greaves. A scholar is included among the top collaborators of Mel Greaves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mel Greaves. Mel Greaves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ford, Anthony M., et al.. (2023). Gut microbiome immaturity and childhood acute lymphoblastic leukaemia. Nature reviews. Cancer. 23(8). 565–576. 21 indexed citations
2.
Pombo‐de‐Oliveira, Maria S., Eleni Petridou, Maria A. Karalexi, et al.. (2022). The Interplay of Cesarean-Section Delivery and First-Birth Order as Risk Factors in Acute Lymphoblastic Leukemia. Cancer Epidemiology Biomarkers & Prevention. 32(3). 371–379. 3 indexed citations
3.
Mansur, Marcela Braga, Caroline L. Furness, Sirintra Nakjang, et al.. (2021). The genomic landscape of teenage and young adult T‐cell acute lymphoblastic leukemia. Cancer Medicine. 10(14). 4864–4873. 9 indexed citations
4.
Palmi, Chiara, Grazia Fazio, Angela Maria Savino, et al.. (2014). Cytoskeletal Regulatory Gene Expression and Migratory Properties of B-cell Progenitors Are Affected by the ETV6–RUNX1 Rearrangement. Molecular Cancer Research. 12(12). 1796–1806. 7 indexed citations
5.
Ma, Yussanne, Sara E. Dobbins, Amy L. Sherborne, et al.. (2013). Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences. 110(18). 7429–7433. 33 indexed citations
6.
Potter, Nicola, Luca Ermini, Elli Papaemmanuil, et al.. (2013). Single-cell mutational profiling and clonal phylogeny in cancer. Genome Research. 23(12). 2115–2125. 86 indexed citations
7.
Cazzaniga, Giovanni, Frederik W. van Delft, Luca Lo Nigro, et al.. (2011). Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Blood. 118(20). 5559–5564. 67 indexed citations
8.
Delft, Frederik W. van, Sharon W. Horsley, Sue Colman, et al.. (2011). Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood. 117(23). 6247–6254. 64 indexed citations
9.
Prasad, Rashmi B., Fay J. Hosking, Jayaram Vijayakrishnan, et al.. (2009). Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood. 115(9). 1765–1767. 91 indexed citations
10.
Ford, Anthony M., Chiara Palmi, Clara Bueno, et al.. (2009). The TEL-AML1 leukemia fusion gene dysregulates the TGF-β pathway in early B lineage progenitor cells. Journal of Clinical Investigation. 119(4). 826–36. 88 indexed citations
11.
Hong, Dengli, Rajeev Gupta, Philip Ancliff, et al.. (2008). Initiating and Cancer-Propagating Cells in TEL-AML1 -Associated Childhood Leukemia. Science. 319(5861). 336–339. 260 indexed citations
12.
Greaves, Mel. (2007). A darwinian eye view of cancer. ˜The œbiomedical & life sciences collection.. 2007(10). e1001522–e1001522. 1 indexed citations
13.
Maia, Ana-Teresa, et al.. (2004). Protracted postnatal natural histories in childhood leukemia. Genes Chromosomes and Cancer. 39(4). 335–340. 47 indexed citations
14.
Greaves, Mel, Ana-Teresa Maia, Joseph L. Wiemels, & Anthony M. Ford. (2003). Leukemia in twins: lessons in natural history. Blood. 102(7). 2321–2333. 340 indexed citations
15.
Kempski, Helena, et al.. (2003). Prenatal chromosomal diversification of leukemia in monozygotic twins. Genes Chromosomes and Cancer. 37(4). 406–411. 16 indexed citations
16.
Quintana, Juan A., et al.. (2001). Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile. Revista médica de Chile. 129(6). 634–42. 3 indexed citations
17.
Wiemels, Joe & Mel Greaves. (1999). Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia.. PubMed. 59(16). 4075–82. 72 indexed citations
18.
Enver, Tariq & Mel Greaves. (1998). Loops, Lineage, and Leukemia. Cell. 94(1). 9–12. 163 indexed citations
19.
McCormick, Christopher J., Lyn Healy, Karin B. Gale, Mel Greaves, & Tariq Enver. (1994). FUNCTIONAL-ANALYSIS OF THE STEM-CELL ANTIGEN CD34 IN TRANSGENIC MICE. UCL Discovery (University College London). 1 indexed citations
20.
Jánossy, G, Mel Greaves, Roger Woodruff, et al.. (1978). Lymphoid blast crisis in chronic myeloid leukaemia and Philadelphia positive acute lymphoid leukaemia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 57(3). 355–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026